Evoli A, Tonali P, Scoppetta C, David P
J Am Geriatr Soc. 1983 Jun;31(6):352-5. doi: 10.1111/j.1532-5415.1983.tb05746.x.
The treatment of myasthenia gravis in the elderly is controversial. Thirty-seven myasthenic patients with onset of the disease after the age of 60 were followed for a period of 14 years. All of the 37 patients received anticholinesterase drugs during this period, ten underwent thymectomy, and 24 were treated with corticosteroids. At present, one patient is in remission, 28 are improved, one is unchanged, and seven have died. Only one death was directly related to myasthenia. In the authors' experience thymectomy can be an effective treatment of myasthenia gravis in elderly patients; corticosteroid therapy can also be useful in addition to or as an alternative to surgery. Using a "personalized" schedule the authors obtained good results in 78 per cent of their patients.
老年重症肌无力的治疗存在争议。对37例60岁以后发病的重症肌无力患者进行了为期14年的随访。在此期间,所有37例患者均接受了抗胆碱酯酶药物治疗,10例接受了胸腺切除术,24例接受了皮质类固醇治疗。目前,1例患者缓解,28例改善,1例无变化,7例死亡。仅1例死亡与重症肌无力直接相关。根据作者的经验,胸腺切除术可以有效治疗老年重症肌无力患者;皮质类固醇治疗作为手术的补充或替代方法也可能有用。通过采用“个性化”方案,作者在78%的患者中取得了良好效果。